Leading GLP-1 persistence, adherence and clinical outcomes research helps inform health plans and members

Studies include Prime’s GLP-1 obesity research, the impact of social determinants of health and more.

Urick, senior principal health outcomes researcher, shares more about his Spotlight Session at the Academy of Managed Care Pharmacy (AMCP)’s Annual Meeting

Prime Therapeutics clinical experts shared insights on the specialty drug pipeline at recent industry event